BBT Capital Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-171,412
Closed -$2.35M 182
2014
Q3
$2.35M Sell
171,412
-19,500
-10% -$278K 0.13% 160
2014
Q2
$3.12M Sell
190,912
-12,500
-6% -$181K 0.19% 121
2014
Q1
$3.2M Buy
203,412
+115,000
+130% +$1.87M 0.15% 173
2013
Q4
$1.52M Buy
88,412
+38,536
+77% +$593K 0.07% 220
2013
Q3
$658K Buy
+49,876
New +$588K 0.03% 253

Other funds holding ANGO

BBT Capital Management's ANGO Position: Q4 2014 in Review

BBT Capital Management sold out of AngioDynamics (ANGO) in Q4 2014, closing a stake of 171,412 shares — an estimated $2.35M sold.

BBT Capital Management first reported a position in ANGO in Q3 2013 and held it in 5 quarters. The position peaked at $3.2M in Q1 2014. 132 funds tracked by Wall St. Rank hold ANGO as of Q4 2014.

  • BBT Capital Management reported no remaining AngioDynamics position as of Q4 2014 after selling out during the quarter.
  • BBT Capital Management sold 171,412 AngioDynamics shares in Q4 2014, an estimated $2.35M.
  • BBT Capital Management first reported a position in AngioDynamics in Q3 2013 and held it in 5 quarters.
  • BBT Capital Management's AngioDynamics position peaked at $3.2M in Q1 2014.
  • 132 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2014.

Based on BBT Capital Management's 13F filing for Q4 2014, filed 10 Feb 2015.